The present invention relates to a pharmaceutical composition comprising a non-nucleoside reverse transcriptase inhibitor (NNRTI), and more particularly, relates to a pharmaceutical composition comprising rilpivirine, a process for preparing such pharmaceutical composition, and its use in the treatment of HIV infections.